Journal
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56
Volume 56, Issue -, Pages 605-626Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev-pharmtox-010715-103209
Keywords
nonalcoholic fatty liver; liver inflammation and fibrosis; viral hepatitis infection; cholestatic liver disease; hepatocellular cancer; drug-induced liver injury
Categories
Funding
- NATIONAL CANCER INSTITUTE [R21CA191507] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104656, R01DK080440] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025909] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA024935, R21AA022482] Funding Source: NIH RePORTER
- Veterans Affairs [I01BX002634] Funding Source: NIH RePORTER
- NCI NIH HHS [R21CA191507, R21 CA191507] Funding Source: Medline
- NIAAA NIH HHS [R21 AA024935, R21 AA022482, R21AA022482] Funding Source: Medline
- NIDDK NIH HHS [R01 DK080440, R01DK104656, R01DK080440, R01 DK104656] Funding Source: Medline
- NIEHS NIH HHS [R01 ES025909, R01ES025909] Funding Source: Medline
- Intramural VA [VA999999] Funding Source: Medline
- BLRD VA [I01 BX002634] Funding Source: Medline
Ask authors/readers for more resources
Nuclear receptors (NR) are ligand-modulated transcription factors that play diverse roles in cell differentiation, development, proliferation, and metabolism and are associated with numerous liver pathologies such as cancer, steatosis, inflammation, fibrosis, cholestasis, and xenobiotic/druginduced liver injury. The network of target proteins associated with NRs is extremely complex, comprising coregulators, small noncoding microRNAs, and long noncoding RNAs. The importance of NRs as targets of liver disease is exemplified by the number of NR ligands that are currently used in the clinics or in clinical trials with promising results. Understanding the regulation by NR during pathophysiological conditions, and identifying ligands for orphan NR, points to a potential therapeutic approach for patients with liver diseases. An overview of complex NR metabolic networks and their pharmacological implications in liver disease is presented here.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available